We are excited to announce that today, Singclean® for ophthalmic surgery is registered with the Directorate General of Drug Supplies and Drugs (DIGEMID) in Peru. It’s obvious that Singclean® for ophthalmic surgery are in high demand in Peru as we have received a lot of inquiries in a long time. So we made a great effort to support the registration process in order to provide an ideal viscoelastic solution for ophthalmic surgery for patients in Peru.
What is Singclean®？
Singclean® works as a surgical aid in ophthalmic anterior and posterior segment surgery including: Cataract extraction, Corneal transparent, Glaucoma, Filtering and Secondary lens implantation. It’s colourless and transparent gel, composed of highly purified sodium hyaluronate dissolved in buffered saline.
When should consider Singclean®？
As viscoelastic solution for ophthalmic surgery, hyaluronic acid can protect tissue out of mechanical damage from surgery device through shock absorption and cell layer lubrication. High maintain the good view for surgery operation.
Specification:
How to use Singclean®:
1. Cataract extraction surgery, IOL implantation: 0.2-0.75ml into anterior chamber, 0.1ml on the IOL spreading.
2. Cataract surgery: 0.1-0.5ml injection into anterior chamber.
3. IOL implantation: before implantation 0.1-0.5 injection into anterior chamber, 0.1ml on the IOL spreading.
4. Corneal transplant surgery: after removal of corneal, 0.1-0.5ml injection into anterior chamber, after transplant of corneal spreading around 0.1ml.
Certification：
CE/ISO13485/ISO9001/CFDA/SGS
-
singclean | 2019-08-27
Singderm Filler Achieves 92.7% Efficacy at 12 Months in Global Clinical Trial, Validated by Landmark Thailand MasterclassBangkok, Thailand – Singderm, a globally certified dermal filler brand, has demonstrated unprecedented clinical performance in its Thailand Masterclass led by renowned physician Dr. Worawat Nolah. Three top KOLs (Hack Anantaya, Chalidaorn PinNy, Thantaya Thuranuch) received multi-zone injections with zero complications, reinforcing Singderm’s 92.7% 12-month efficacy rate from a 100-subject clinical trial. -
singclean | 2019-08-27
Singclean to Showcase Innovative Medical Solutions at Key International Exhibitions in Bangkok and Copenhagen -
singclean | 2019-08-27
Singclean Medical Shines at WHX Kuala Lumpur 2025, IVD Solutions Garner Strong Attention Across ASEANKuala Lumpur, Malaysia | July 18, 2025 — From July 16 to 18, WHX Kuala Lumpur 2025, one of ASEAN’s most influential exhibitions for medical devices and laboratory equipment, took place in the Malaysian capital. The event gathered global healthcare technology leaders, and Singclean Medical, a leading Chinese in-vitro diagnostics (IVD) company, made a strong impression with its innovative and reliable total IVD solutions. Backed by solid product performance and technological excellence, Singclean attracted wide interest and recognition from professional attendees.
